(Q46226519)

20 December 2017

title

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections - the European experience (English)

1 reference

20 December 2017

author name string

P Fomin

1

1 reference

20 December 2017

S Koalov

2

1 reference

20 December 2017

A Cooper

3

1 reference

20 December 2017

T Babinchak

4

1 reference

20 December 2017

N Dartois

5

1 reference

20 December 2017

N De Vane

6

1 reference

20 December 2017

N Castaing

7

1 reference

20 December 2017

J Tellado

8

1 reference

20 December 2017

301 And 306 Study Groups

9

1 reference

20 December 2017

language of work or name

1 reference

1 October 2008

1 reference

20 December 2017

published in

Journal of Chemotherapy

1 reference

20 December 2017

volume

20 Suppl 1

1 reference

20 December 2017

page(s)

12-19

1 reference

20 December 2017

Critical issues in the clinical management of complicated intra-abdominal infections

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

CTX-M: changing the face of ESBLs in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

New approaches in the treatment of bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

Quality of care, process, and outcomes in elderly patients with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

The impact of antimicrobial resistance on health and economic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

Severity-of-illness markers as predictors of nosocomial infection in adult intensive care unit patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

Intensive care unit management of intra-abdominal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

Antimicrobial treatment for intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.12

10.1179/JOC.2008.20.SUPPLEMENT-1.12

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017